ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Twenty Apply for ICC Director Job, DeVita Says 30 More Centers Needed; PAP Awards To Clark, Fox

March 18, 1983

NCI To Pilot Text Chat On CancerNet And CIS Sites.

September 29, 2000

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

Study Needs 23,000 Women Whose Sisters Have Cancer

September 29, 2006